November 2021

InvoX

InvoX

Financial Adviser (Buy side)

Results Healthcare Has Advised InvoX on its Strategic Investment in a UK Biotech

More Like This

US$29m

September 2025

Lucid Diagnostics

Joint Bookrunner (Follow-On Offering)
US$637m

September 2025

Vitruvian Partners

Advisor to Vitruvian Partners on its $637 Million Investment in DeepIntent
August 2025

Kooth

Appointed as Joint Broker

View all Healthcare transactions